potassium channel tetramerization domain containing 1
Última actualización 18 Aug 2020
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
El KCTD1 gene provides instructions for making a protein that acts as a transcriptional repressor, which means that it turns off (represses) the activity of certain genes when they are not needed. A region of the KCTD1 protein called the BTB domain is essential for the protein's transcriptional repressor function.
Selecciones de videos para GenesBiblioteca de videos
Normal function
El KCTD1 gene provides instructions for making a protein that acts as a transcriptional repressor, which means that it turns off (represses) the activity of certain genes when they are not needed. A region of the KCTD1 protein called the BTB domain is essential for the protein's transcriptional repressor function.
The KCTD1 protein is thought to control (regulate) the activity of genes involved in the development of an embryonic cell layer called the ectoderm. Within the developing embryo, the ectoderm gives rise to several body tissues including the skin, hair, nails, and teeth.
Conditions referring to this gene or chromosome
Otros nombres
C18orf5
potassium channel tetramerisation domain containing 1
potassium channel tetramerization domain-containing protein 1
SENS
Related patient information and medicines

Patient information leaflet
¿Puedo tomar Atorvastatina y Eplerenona juntos?
It is generally safe to take these two medications together. Why this happens Atorvastatina es a cholesterol-lowering medicine (statin) and eplerenone es a potassium-sparing diuretic (water pill). They are processed by the body using different pathways and do not interfere with how the other works. Salt substitutes (containing potassium) Eplerenone.

Patient information leaflet
¿Puedo tomar Candesartán y Matcha juntos?
Drinking matcha while taking candesartan may cause your blood pressure to drop lower than intended. ... High potassium (Hyperkalaemia) Candesartan increases potassium levels in your blood. Matcha also contains significant potassium. Potassium-rich foods (e.g., bananas, spinach, salt substitutes) Candesartan can increase the levels of potassium in.

Patient information leaflet
¿Puedo tomar aceite de hígado de bacalao y eplerenona juntos?
Tomar cod liver oil and eplerenone together may slightly increase the risk of your blood pressure dropping too low or may affect your potassium levels, though the risk is generally low. Why this happens Cod liver oil contains omega-3 fatty acids, which have a mild blood-pressure-lowering effect. Eplerenone is a medicine specifically designed to.

Patient information leaflet
¿Puedo tomar Ramipril y Vitamina D juntos?
There is no known direct interaction between ramipril and vitamin D supplements. It is generally considered safe to take these two together. Why this happens Ramipril is an ACE inhibitor used for blood pressure, and Vitamin D is a fat-soluble vitamin. They are processed by different pathways in the body and do not interfere with each other's.

Patient information leaflet
¿Puedo tomar Candesartán y Condroitina juntos?
There are no known significant interactions between candesartan and chondroitin. It is generally considered safe to take these two together. Why this happens Candesartan is a blood pressure medication (angiotensin II receptor blocker) that is processed by the liver and kidneys. Chondroitin is a supplement used for joint health. These two.

Patient information leaflet
¿Puedo tomar Candesartán y Eplerenona juntos?
Taking these two medicines together can significantly increase the level of potassium in your blood (a condition called hyperkalaemia). While both drugs are used to treat heart conditions or high blood pressure, having too much potassium can be dangerous and may lead to serious heart rhythm problems. Why this happens Both candesartan and.
Lecturas adicionales y referencias
- potassium channel tetramerization domain containing 1; MedlinePlus, National Library of Medicine.
- Ding XF, Luo C, Ren KQ, Zhang J, Zhou JL, Hu X, Liu RS, Wang Y, Gao X, Zhang J. Characterization and expression of a human KCTD1 gene containing the BTB domain, which mediates transcriptional repression and homomeric interactions. DNA Cell Biol. 2008 May;27(5):257-65. doi: 10.1089/dna.2007.0662.
- Li X, Chen C, Wang F, Huang W, Liang Z, Xiao Y, Wei K, Wan Z, Hu X, Xiang S, Ding X, Zhang J. KCTD1 suppresses canonical Wnt signaling pathway by enhancing beta-catenin degradation. PLoS One. 2014 Apr 15;9(4):e94343. doi: 10.1371/journal.pone.0094343. eCollection 2014.
- Marneros AG, Beck AE, Turner EH, McMillin MJ, Edwards MJ, Field M, de Macena Sobreira NL, Perez AB, Fortes JA, Lampe AK, Giovannucci Uzielli ML, Gordon CT, Plessis G, Le Merrer M, Amiel J, Reichenberger E, Shively KM, Cerrato F, Labow BI, Tabor HK, Smith JD, Shendure J, Nickerson DA, Bamshad MJ; University of Washington Center for Mendelian Genomics. Mutations in KCTD1 cause scalp-ear-nipple syndrome. Am J Hum Genet. 2013 Apr 4;92(4):621-6. doi: 10.1016/j.ajhg.2013.03.002. Epub 2013 Mar 28.
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

